Trial Profile
A Non-Interventional Study Evaluating Well-Being/Quality of Life in Schizophrenic Patients Treated With Seroquel XR (Quetiapine) and Other Atypical Antipsychotics. A 9-Month, Observational, Multicentric Prospective Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2010
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Antipsychotics
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms Xperience
- Sponsors AstraZeneca
- 03 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Apr 2009 Planned end date changed from 1 Dec 2009 to 1 Jan 2010 as reported by ClinicalTrials.gov.